Ignite Creation Date:
2024-05-06 @ 10:06 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03164603
Status:
COMPLETED
Last Update Posted:
2020-06-04
First Post:
2017-05-22
Brief Title:
NLG802 Indoleamine 23-Dioxygenase IDO Inhibitor in Advanced Solid Tumors
Sponsor:
NewLink Genetics Corporation
Organization:
Lumos Pharma
Organization Data
Organization:
Lumos Pharma
Class:
INDUSTRY
Study ID:
NLG8021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NewLink Genetics Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None